Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $164.06 million. The enterprise value is $18.36 million.
| Market Cap | 164.06M |
| Enterprise Value | 18.36M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TRDA has 36.06 million shares outstanding. The number of shares has increased by 2.00% in one year.
| Current Share Class | 36.06M |
| Shares Outstanding | 36.06M |
| Shares Change (YoY) | +2.00% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 52.66% |
| Float | 22.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.25 |
| Forward PS | 4.93 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.24.
| Current Ratio | 7.85 |
| Quick Ratio | 7.50 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.88% and return on invested capital (ROIC) is -303.41%.
| Return on Equity (ROE) | -59.88% |
| Return on Assets (ROA) | -31.12% |
| Return on Invested Capital (ROIC) | -303.41% |
| Return on Capital Employed (ROCE) | -70.23% |
| Weighted Average Cost of Capital (WACC) | 2.64% |
| Revenue Per Employee | $26,164 |
| Profits Per Employee | -$1.06M |
| Employee Count | 152 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $192,000 in taxes.
| Income Tax | 192,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.27% in the last 52 weeks. The beta is -0.15, so TRDA's price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | -31.27% |
| 50-Day Moving Average | 5.84 |
| 200-Day Moving Average | 8.65 |
| Relative Strength Index (RSI) | 43.36 |
| Average Volume (20 Days) | 425,536 |
Short Selling Information
The latest short interest is 3.27 million, so 9.07% of the outstanding shares have been sold short.
| Short Interest | 3.27M |
| Short Previous Month | 2.99M |
| Short % of Shares Out | 9.07% |
| Short % of Float | 14.43% |
| Short Ratio (days to cover) | 9.53 |
Income Statement
In the last 12 months, TRDA had revenue of $3.98 million and -$161.39 million in losses. Loss per share was -$3.84.
| Revenue | 3.98M |
| Gross Profit | -136.59M |
| Operating Income | -169.26M |
| Pretax Income | -161.19M |
| Net Income | -161.39M |
| EBITDA | -166.06M |
| EBIT | -169.26M |
| Loss Per Share | -$3.84 |
Balance Sheet
The company has $193.02 million in cash and $47.31 million in debt, with a net cash position of $145.70 million or $4.04 per share.
| Cash & Cash Equivalents | 193.02M |
| Total Debt | 47.31M |
| Net Cash | 145.70M |
| Net Cash Per Share | $4.04 |
| Equity (Book Value) | 198.33M |
| Book Value Per Share | 5.07 |
| Working Capital | 177.09M |
Cash Flow
In the last 12 months, operating cash flow was -$136.33 million and capital expenditures -$9,000, giving a free cash flow of -$136.33 million.
| Operating Cash Flow | -136.33M |
| Capital Expenditures | -9,000 |
| Depreciation & Amortization | 3.20M |
| Net Borrowing | n/a |
| Free Cash Flow | -136.33M |
| FCF Per Share | -$3.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,256.05% |
| Pretax Margin | -4,053.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.00% |
| Shareholder Yield | -2.00% |
| Earnings Yield | -84.43% |
| FCF Yield | -83.10% |
Analyst Forecast
The average price target for TRDA is $19.00, which is 317.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 317.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | -7.85% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |